Article Details
Retrieved on: 2023-01-13 14:04:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In summer 2022, the US Food and Drug Administration (FDA) approved the treatment for adolescents and adults. The phase 2 long-term safety study ...
Article found on: www.dermatologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here